{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:06:38Z","timestamp":1793066798459,"version":"4.5.0"},"reference-count":475,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000839","name":"University of Reading","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbcan.2025.189479","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:26:31Z","timestamp":1760743591000},"page":"189479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies"],"prefix":"10.1016","volume":"1880","author":[{"given":"Jos\u00e9 R.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Pinos-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto A.","family":"Robles-Loaiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony Abdi","family":"Syahputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Gabriela Silva","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy Iara Maciel de A.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189479_bb0005","article-title":"Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective","volume":"28","author":"Pi\u00f1a-S\u00e1nchez","year":"2021","journal-title":"Cancer Contr. J. Moffitt Cancer Center"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0010","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0015","first-page":"6385","article-title":"The economic impact of cancer diagnosis to individuals and their families: a systematic review","volume":"30","author":"Alzehr","year":"2022","journal-title":"Support. Care Cancer"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189479_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133158","article-title":"Economic perspective of cancer care and its consequences for vulnerable groups","volume":"14","author":"Haier","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0025","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2025.189479_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102290","article-title":"Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000\u201319: a pointer to national trajectories towards achieving Sustainable Development goal target 3.4","volume":"100","author":"Bray","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mayocpiqo.2021.05.005","article-title":"Cancer mortality rates increasing vs cardiovascular disease mortality decreasing in the world: future implications, mayo clinic proceedings","volume":"5","author":"ReFaey","year":"2021","journal-title":"Innov. Qual. Outcomes"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jncc.2024.05.002","article-title":"Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study","volume":"4","author":"Li","year":"2024","journal-title":"J. Nation. Cancer Center"},{"key":"10.1016\/j.bbcan.2025.189479_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103193","article-title":"Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022","volume":"83","author":"Sun","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.bbcan.2025.189479_bb0055","article-title":"Perspective: rethinking therapeutic strategies in oncology","volume":"13","author":"Patz","year":"2023","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105296","article-title":"Innovation through tradition: the current challenges in cancer treatment","volume":"23","author":"Sapio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0065","first-page":"209","article-title":"Conventional chemotherapy: millions of cures, unresolved therapeutic index","volume":"25","author":"Letai","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0070","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbcan.2025.189479_bb0075","doi-asserted-by":"crossref","first-page":"SII9","DOI":"10.1016\/S0140-6736(98)90327-0","article-title":"Conventional cancer therapy: promise broken or promise delayed?","volume":"351","author":"Tannock","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Sign. Transd. Target. Therapy"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-024-03793-1","article-title":"Novel treatment strategies for hematological malignancies in the immunotherapy era","volume":"120","author":"Imai","year":"2024","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0095","article-title":"Novel medicines and strategies in cancer treatment and prevention","volume":"2014","author":"Tang","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0100","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.molcel.2020.05.031","article-title":"Rational cancer treatment combinations: an urgent clinical need","volume":"78","author":"Boshuizen","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41597-024-02915-y","article-title":"Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer","volume":"11","author":"Hu","year":"2024","journal-title":"Sci Data"},{"issue":"3-4","key":"10.1016\/j.bbcan.2025.189479_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1142\/S2339547818300020","article-title":"The growing role of precision and personalized medicine for cancer treatment","volume":"6","author":"Krzyszczyk","year":"2018","journal-title":"Technology"},{"key":"10.1016\/j.bbcan.2025.189479_bb0115","article-title":"Personalized medicine: an alternative for cancer treatment","volume":"42","author":"Singh","year":"2024","journal-title":"Cancer Treatm. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0120","first-page":"144","article-title":"Integrative oncology: addressing the global challenges of cancer prevention and treatment","volume":"72","author":"Mao","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0125","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0135","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist. (Alhambra, Calif.)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12885-016-2999-1","article-title":"Molecular chess? Hallmarks of anti-cancer drug resistance","volume":"17","author":"Cree","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.265","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm"},{"issue":"23","key":"10.1016\/j.bbcan.2025.189479_bb0155","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0160","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1383\/surg.2006.24.2.70","article-title":"Principles of cancer treatment by surgery","volume":"24","author":"Reed","year":"2006","journal-title":"Surgery (Oxford)"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mpsur.2021.02.002","article-title":"Principles of cancer treatment by radiotherapy","volume":"39","author":"Vaidya","year":"2021","journal-title":"Surgery (Oxford)"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb0180","series-title":"Disclosure: Vikas Gupta Declares No Relevant Financial Relationships with Ineligible Companies","article-title":"Adverse Effects of Radiation Therapy, StatPearls, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies","author":"Majeed","year":"2025"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Diseas."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1023565227808","article-title":"Toxicity patterns of cytotoxic drugs","volume":"21","author":"Chatelut","year":"2003","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbcan.2025.189479_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-031-27156-4_12","article-title":"Cancer chemoresistance; Recent challenges and future considerations","volume":"185","author":"Adil","year":"2023","journal-title":"Cancer Treat. Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-022-01677-0","article-title":"Innovation in cancer therapeutics and regulatory perspectives","volume":"39","author":"Sharma","year":"2022","journal-title":"Med. Oncol. (Northwood, London, England)"},{"key":"10.1016\/j.bbcan.2025.189479_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: pros, cons and beyond","volume":"124","author":"Tan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189479_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248867","article-title":"The future of affordable cancer immunotherapy","volume":"14","author":"Schaft","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-031-27156-4_6","article-title":"Hormonal therapies in cancers","volume":"185","author":"Tariq","year":"2023","journal-title":"Cancer Treat. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mpmed.2015.10.014","article-title":"Hormonal therapy for cancer","volume":"44","author":"Abraham","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000508675","article-title":"Endocrine-resistant breast cancer: mechanisms and treatment","volume":"15","author":"Hartkopf","year":"2020","journal-title":"Breast Care (Basel, Switzerland)"},{"issue":"53","key":"10.1016\/j.bbcan.2025.189479_bb0230","article-title":"Potential successes and challenges of targeted cancer therapies, Journal of the National Cancer Institute","volume":"2019","author":"Keefe","year":"2019","journal-title":"Monographs"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0235","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40291-023-00662-1","article-title":"Omidubicel: first approval","volume":"27","author":"Heo","year":"2023","journal-title":"Mol. Diagnos. Therapy"},{"key":"10.1016\/j.bbcan.2025.189479_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.acr.2015.04.012","article-title":"Stem cell-based therapies for cancer","volume":"127","author":"Bhere","year":"2015","journal-title":"Adv. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd1722","article-title":"Cancer drug discovery through collaboration, Nature reviews","volume":"4","author":"Lengauer","year":"2005","journal-title":"Drug Des. Discov."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189479_bb0250","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.3390\/ijms241612931","article-title":"Peptide-based agents for cancer treatment: current applications and future directions","volume":"24","author":"Nh\u00e0n","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122919","article-title":"Feature collection in peptide therapeutics: current applications and future directions","volume":"12","author":"Lebleu","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Sign. Transd. Target. Therapy"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300256","article-title":"Advances in biosynthesis of peptide drugs: technology and industrialization","volume":"19","author":"Wang","year":"2024","journal-title":"Biotechnol. J."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0275","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/antibiotics13030196","article-title":"The century-long journey of peptide-based drugs","volume":"13","author":"Almeida","year":"2024","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/2211-5463.13847","article-title":"Structural information in therapeutic peptides: emerging applications in biomedicine","volume":"15","author":"Iglesias","year":"2025","journal-title":"FEBS Open Bio"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0295","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/cancers16051032","article-title":"Peptide therapeutics: unveiling the potential against cancer\u2014a journey through 1989","volume":"16","author":"Al Musaimi","year":"2024","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189479_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612931","article-title":"Peptide-based agents for cancer treatment: current applications and future directions","volume":"24","author":"Nh\u00e0n","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114996","article-title":"Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications","volume":"164","author":"Chinnadurai","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189479_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100071","article-title":"Commercial manufacturing of current good manufacturing practice peptides spanning the gamut from neoantigen to commercial large-scale products","volume":"9","author":"Pennington","year":"2021","journal-title":"Med. Drug Discov."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0315","doi-asserted-by":"crossref","DOI":"10.4155\/fdd-2022-0005","article-title":"Overcoming the shortcomings of peptide-based therapeutics","volume":"4","author":"Lamers","year":"2022","journal-title":"Future Drug Discov."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0320","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00044-024-03269-1","article-title":"Peptide-based therapeutics: challenges and solutions","volume":"33","author":"Pereira","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0325","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","article-title":"Peptidomimetic therapeutics: scientific approaches and opportunities","volume":"22","author":"Qvit","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0330","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/pros.20115","article-title":"Androgen deprivation therapy for prostate cancer: Current status and future prospects","volume":"61","author":"Miyamoto","year":"2004","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0335","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1517\/13543784.16.11.1851","article-title":"Leuprolide acetate: a drug of diverse clinical applications","volume":"16","author":"Wilson","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0340","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ajog.2004.06.100","article-title":"European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia","volume":"191","author":"Mansel","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0345","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.10062","article-title":"Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature","volume":"79","author":"Leong","year":"2002","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02996303","article-title":"Biodistribution on Tc-99m labeled somatostatin receptor-binding peptide (Depreotide, NeoTec) planar and SPECT studies","volume":"16","author":"Shih","year":"2002","journal-title":"Ann. Nucl. Med."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189479_bb0355","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1080\/14656566.2019.1650020","article-title":"Evaluating triptorelin as a treatment option for breast cancer","volume":"20","author":"Ferraro","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb0360","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple Myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0365","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1517\/14656566.5.10.2171","article-title":"Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer","volume":"5","author":"Mongiat-Artus","year":"2004","journal-title":"Expert. Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0370","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40265-014-0211-y","article-title":"Degarelix: a review of its use in patients with prostate cancer","volume":"74","author":"Carter","year":"2014","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0375","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-10-459883","article-title":"Carfilzomib","volume":"121","author":"Kortuem","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0380","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.bbcan.2025.189479_bb0385","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.18632\/oncotarget.27695","article-title":"Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: a retrospective analysis in neuroendocrine tumor patients","volume":"11","author":"Chauhan","year":"2020","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0390","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb0395","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"<sup>68<\/sup>Ga-DOTATOC versus <sup>68<\/sup>Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","author":"Poeppel","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2967\/jnumed.120.244509","article-title":"<sup>64<\/sup>Cu-DOTATATE PET in patients with neuroendocrine neoplasms: prospective, head-to-head comparison of imaging at 1 hour and 3 hours after injection","volume":"62","author":"Loft","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0405","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41551-023-01060-y","article-title":"Simultaneous quantitative imaging of two PET radiotracers via the detection of positron\u2013electron annihilation and prompt gamma emissions","volume":"7","author":"Pratt","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0410","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000001698","article-title":"A phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane Antigen PET\/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY)","volume":"206","author":"Pienta","year":"2021","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0415","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (PluvictoTM): the first FDA-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0420","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40265-022-01704-4","article-title":"Tebentafusp: first approval","volume":"82","author":"Dhillon","year":"2022","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0425","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s40291-023-00665-y","article-title":"Flotufolastat F 18: diagnostic first approval","volume":"27","author":"Heo","year":"2023","journal-title":"Mol. Diagnos. Therapy"},{"issue":"17","key":"10.1016\/j.bbcan.2025.189479_bb0430","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s40265-023-01962-w","article-title":"Motixafortide: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0435","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/ph18030291","article-title":"2024 FDA TIDES (Peptides and Oligonucleotides) harvest","volume":"18","author":"Al Musaimi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0440","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","article-title":"Peptides as multifunctional players in cancer therapy","volume":"55","author":"Vadevoo","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0445","doi-asserted-by":"crossref","DOI":"10.4103\/RPS.RPS_75_24","article-title":"Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment","volume":"20","author":"Ghavimi","year":"2025","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb0450","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2020.10.009","article-title":"Multifunctional peptides for tumor therapy","volume":"160","author":"Li","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0455","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/jca.15309","article-title":"Effects of animal venoms and toxins on hallmarks of cancer","volume":"7","author":"Chaisakul","year":"2016","journal-title":"J. Cancer"},{"issue":"30","key":"10.1016\/j.bbcan.2025.189479_bb0460","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.2174\/0929867323666161028155611","article-title":"Snake venom peptides and low mass proteins: molecular tools and therapeutic agents","volume":"24","author":"Almeida","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0465","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jat.4544","article-title":"Snake venom toxins: potential anticancer therapeutics","volume":"44","author":"Offor","year":"2024","journal-title":"J. Appl. Toxicol."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189479_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314686","article-title":"First insights into the venom composition of two ecuadorian coral snakes","volume":"23","author":"Hern\u00e1ndez-Altamirano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0475","article-title":"Snake venoms in drug discovery: valuable therapeutic tools for life saving","volume":"11","author":"Abd El-Aziz","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0480","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2013.03.020","article-title":"Snake venomics: from the inventory of toxins to biology","volume":"75","author":"Calvete","year":"2013","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0485","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s42003-024-06019-6","article-title":"Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies","volume":"7","author":"Bittenbinder","year":"2024","journal-title":"Commun. Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb0490","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/toxins14120884","article-title":"Toxic habits: an analysis of general trends and biases in snake venom research","volume":"14","author":"Avella","year":"2022","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0495","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41570-022-00393-7","article-title":"The chemistry of snake venom and its medicinal potential","volume":"6","author":"Oliveira","year":"2022","journal-title":"Nat. Rev. Chem."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2025.189479_bb0500","article-title":"Unlocking the potential of snake venom-based molecules against the malaria, Chagas disease, and leishmaniasis triad","volume":"242","author":"Almeida","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0505","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0510","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1101\/gr.3228405","article-title":"From genome to \u201cvenome\u201d: molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins","volume":"15","author":"Fry","year":"2005","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15010074","article-title":"Highly evolvable: investigating interspecific and intraspecific venom variation in taipans (Oxyuranus spp.) and Brown Snakes (Pseudonaja spp.)","volume":"15","author":"van Thiel","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0520","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2021.01.007","article-title":"Bothrops atrox from Ecuadorian Amazon: initial analyses of venoms from individuals","volume":"193","author":"Pati\u00f1o","year":"2021","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109651","article-title":"Functional variability of snake venom metalloproteinases: adaptive advantages in targeting different prey and implications for human envenomation","volume":"9","author":"Bernardoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189479_bb0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2017.06.010","article-title":"Phospholipase A(2) in the venom of three cottonmouth snakes","volume":"135","author":"Jia","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0535","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxicon.2017.01.002","article-title":"Exploring and understanding the functional role, and biochemical and structural characteristics of an acidic phospholipase A2, AplTx-I, purified from Agkistrodon piscivorus leucostoma snake venom","volume":"127","author":"Resende","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0540","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijbiomac.2021.01.187","article-title":"Structural, enzymatic and pharmacological profiles of AplTX-II - a basic sPLA2 (D49) isolated from the Agkistrodon piscivorus leucostoma snake venom","volume":"175","author":"Resende","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0545","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s11030-023-10734-3","article-title":"Three finger toxins of elapids: structure, function, clinical applications and its inhibitors","volume":"28","author":"Hiremath","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bbcan.2025.189479_bb0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxicon.2016.09.008","article-title":"Venoms of micrurus coral snakes: evolutionary trends in compositional patterns emerging from proteomic analyses","volume":"122","author":"Lomonte","year":"2016","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb0555","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0560","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/toxins13060427","article-title":"Old world vipers\u2014a review about snake venom proteomics of viperinae and their variations","volume":"13","author":"Damm","year":"2021","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0565","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pmic.200700777","article-title":"Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures","volume":"8","author":"Fox","year":"2008","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0570","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/17460441.2025.2465364","article-title":"The application of snake venom in anticancer drug discovery: an overview of the latest developments","volume":"20","author":"da Silva","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10110474","article-title":"Snake venom peptides: tools of biodiscovery","volume":"10","author":"Munawar","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2020.05.006","article-title":"Putting the brakes on tumorigenesis with snake venom toxins: new molecular insights for cancer drug discovery","volume":"80","author":"Urra","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2016.03.008","article-title":"Biochemical and functional studies of ColTx-I, a new myotoxic phospholipase A2 isolated from Crotalus oreganus lutosus (Great Basin rattlesnake) snake venom","volume":"117","author":"Almeida","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108581","article-title":"Molecular dynamics of Lys49 PLA2-like toxins: insights into solution and membrane-bound conformations","volume":"267","author":"Rach\u00e3o","year":"2025","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0595","article-title":"Snake venom disintegrins update: insights about new findings","volume":"29","author":"Almeida","year":"2023","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/biology12060765","article-title":"Monitoring snake venom-induced extracellular matrix degradation and identifying proteolytically active venom toxins using fluorescently labeled substrates","volume":"12","author":"Bittenbinder","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bbcan.2025.189479_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105041","article-title":"Dissection of phospholipases A(2) reveals multifaceted peptides targeting cancer cells, Leishmania and Bacteria","volume":"114","author":"Pe\u00f1a-Carrillo","year":"2021","journal-title":"Bioorgan. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122352","article-title":"Advances in venomics: modern separation techniques and mass spectrometry","volume":"1160","author":"Abd El-Aziz","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.bbcan.2025.189479_bb0615","article-title":"Mutual enlightenment: a toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance","volume":"X 9-10","author":"Calvete","year":"2021","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0620","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jasms.2006.11.007","article-title":"Proteomic profiling of a snake venom using high mass detection MALDI-TOF mass spectrometry","volume":"18","author":"Yanes","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0625","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mas.21850","article-title":"Quantification of snake venom proteomes by mass spectrometry-considerations and perspectives","volume":"43","author":"Calvete","year":"2024","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.bbcan.2025.189479_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.768015","article-title":"Investigating toxin diversity and abundance in snake venom proteomes","volume":"12","author":"Tasoulis","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107841","article-title":"Exploring snake venoms beyond the primary sequence: from proteoforms to protein-protein interactions","volume":"247","author":"Wang","year":"2024","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0640","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40409-017-0135-6","article-title":"It is time for top-down venomics","volume":"23","author":"Melani","year":"2017","journal-title":"J. Venom. Anim. Toxins Includ. Tropic. Diseas."},{"key":"10.1016\/j.bbcan.2025.189479_bb0645","article-title":"Modern venomics\u2014current insights, novel methods, and future perspectives in biological and applied animal venom research","volume":"11","author":"von Reumont","year":"2022","journal-title":"GigaScience"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0650","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14789450.2018.1500904","article-title":"Snake venomics - from low-resolution toxin-pattern recognition to toxin-resolved venom proteomes with absolute quantification","volume":"15","author":"Calvete","year":"2018","journal-title":"Exp. Rev. Proteom."},{"key":"10.1016\/j.bbcan.2025.189479_bb0655","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40409-017-0117-8","article-title":"Strategies in 'snake venomics' aiming at an integrative view of compositional, functional, and immunological characteristics of venoms","volume":"23","author":"Lomonte","year":"2017","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0660","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond*","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ht7030019","article-title":"Venomics: a mini-review","volume":"7","author":"Wilson","year":"2018","journal-title":"High-throughput"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0670","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/BIO04106028","article-title":"Snake venomics at the crossroads between ecological and clinical toxinology","volume":"41","author":"Calvete","year":"2019","journal-title":"Biochemist"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb0675","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1039\/C6MB00516K","article-title":"Advances in venomics","volume":"12","author":"Oldrati","year":"2016","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bbcan.2025.189479_bb0680","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jprot.2016.02.003","article-title":"Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)","volume":"136","author":"Lauridsen","year":"2016","journal-title":"J. Proteome"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0685","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.febslet.2009.03.029","article-title":"Venoms, venomics, antivenomics","volume":"583","author":"Calvete","year":"2009","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9050158","article-title":"Third generation antivenomics: pushing the limits of the in vitro preclinical assessment of antivenoms","volume":"9","author":"Pla","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0695","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jprot.2016.08.024","article-title":"Exploring the venom of the forest cobra snake: toxicovenomics and antivenom profiling of Naja melanoleuca","volume":"150","author":"Lauridsen","year":"2017","journal-title":"J. Proteome"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0700","doi-asserted-by":"crossref","DOI":"10.5620\/eaht.2024001","article-title":"Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells","volume":"39","author":"Abdallah","year":"2024","journal-title":"Environ. Analys. Health Toxicol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0705","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/ph15060724","article-title":"Purification, characterization and evaluation of the antitumoral activity of a Phospholipase A2 from the Snake Bothrops moojeni","volume":"15","author":"Frihling","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0710","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1021\/acs.jproteome.2c00780","article-title":"High-throughput venomics","volume":"22","author":"Slagboom","year":"2023","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007802","article-title":"High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches","volume":"14","author":"Slagboom","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011564","article-title":"Development of a high-throughput in vitro screening method for the assessment of cell-damaging activities of snake venoms","volume":"17","author":"Bittenbinder","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0725","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10989-011-9254-z","article-title":"Isolation and characterization of a natriuretic peptide from crotalus oreganus abyssus (grand canyon rattlesnake) and its effects on systemic blood pressure and nitrite levels","volume":"17","author":"Da Silva","year":"2011","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189479_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24152778","article-title":"Hypotensive snake venom components-a mini-review","volume":"24","author":"P\u00e9terfi","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11050303","article-title":"From snake venom's disintegrins and C-Type lectins to anti-platelet drugs","volume":"11","author":"Lazarovici","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0740","first-page":"205","article-title":"Effects du venin de cobra sur les greffes cancereuses et sur le cancer spontane (adeno-carcinome) de la souris","volume":"197","author":"Calmette","year":"1933","journal-title":"CR Acad. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0745","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12272-012-0512-1","article-title":"Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor \u03baB and signal transducer and activator of transcription 3","volume":"35","author":"Song","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb0750","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxicon.2018.05.004","article-title":"Whole snake venoms: cytotoxic, anti-metastatic and antiangiogenic properties","volume":"150","author":"Kerkkamp","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0755","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/203639","article-title":"Antitumoral activity of snake venom proteins: new trends in cancer therapy","volume":"2014","author":"Calderon","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189479_bb0760","doi-asserted-by":"crossref","first-page":"13289","DOI":"10.1016\/S0021-9258(18)51627-6","article-title":"Nigexine, a phospholipase A2 from cobra venom with cytotoxic properties not related to esterase activity: purification, amino acid sequence, and biological properties","volume":"264","author":"Chwetzoff","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0765","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/B:JOPC.0000027852.92208.60","article-title":"Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu Venom","volume":"23","author":"Roberto","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.bbcan.2025.189479_bb0770","first-page":"42","article-title":"Purification of a phospholipase A(2) from Daboia russelii siamensis venom with anticancer effects","volume":"2","author":"Khunsap","year":"2011","journal-title":"J. Venom Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb0775","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxicon.2013.08.052","article-title":"A cytotoxic protein (BF-CT1) purified from Bungarus fasciatus venom acts through apoptosis, modulation of PI3K\/AKT, MAPKinase pathway and cell cycle regulation","volume":"74","author":"Bhattacharya","year":"2013","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0780","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biologicals.2009.01.010","article-title":"Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region","volume":"37","author":"Gebrim","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.bbcan.2025.189479_bb0785","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.05.164","article-title":"Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells","volume":"135","author":"de Vasconcelos Azevedo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0790","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxicon.2013.05.017","article-title":"Cytotoxic activities of [Ser49]phospholipase A2 from the venom of the saw-scaled vipers Echis ocellatus, Echis pyramidum leakeyi, Echis carinatus sochureki, and Echis coloratus","volume":"71","author":"Conlon","year":"2013","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0795","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.bbcan.2025.189479_bb0800","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijbiomac.2018.06.082","article-title":"Genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) homologue from Bothrops pauloensis snake venom, on MDA-MB-231 breast cancer cells","volume":"118","author":"Silva","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0805","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.toxicon.2009.01.003","article-title":"Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration","volume":"53","author":"Zouari-Kessentini","year":"2009","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb0810","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/toxins11110661","article-title":"ACP-TX-I and ACP-TX-II, two novel Phospholipases A2 Isolated from trans-pecos copperhead agkistrodon contortrix pictigaster venom: biochemical and functional characterization","volume":"11","author":"Huancahuire-Vega","year":"2019","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0815","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.toxicon.2007.10.006","article-title":"B chain is a functional subunit of \u03b2-bungarotoxin for inducing apoptotic death of human neuroblastoma SK-N-SH cells","volume":"51","author":"Cheng","year":"2008","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0820","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.matbio.2009.03.007","article-title":"MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration","volume":"28","author":"Bazaa","year":"2009","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0825","article-title":"\u03b2-micrustoxin (Mlx-9), a PLA(2) from Micrurus lemniscatus snake venom: biochemical characterization and anti-proliferative effect mediated by p53","volume":"28","author":"Dos Santos","year":"2022","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0830","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0041-0101(97)00097-4","article-title":"Purification and characterization of three acidic, cytotoxic phospholipases A2 from Indian cobra (Naja naja naja) venom","volume":"36","author":"Rudrammaji","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2022.106965","article-title":"The antineoplastic potential of crotoxin isolated from Crotalus durissus terrificus snake venom on oral squamous cell carcinoma","volume":"221","author":"da Rocha","year":"2023","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0840","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1745-7254.2007.00530.x","article-title":"Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells","volume":"28","author":"Yan","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0845","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jcb.21979","article-title":"Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation","volume":"106","author":"Chen","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2025.189479_bb0850","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijbiomac.2022.03.111","article-title":"Functional, immunological characterization, and anticancer activity of BaMtx: a new Lys49- PLA2 homologue isolated from the venom of Peruvian Bothrops atrox snake (Serpentes: Viperidae)","volume":"206","author":"Prole\u00f3n","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb0855","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1271\/bbb.100783","article-title":"A [Lys49]phospholipase A\u2082 from Protobothrops flavoviridis venom induces caspase-independent apoptotic cell death accompanied by rapid plasma-membrane rupture in human leukemia cells","volume":"75","author":"Murakami","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0860","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/toxins5020203","article-title":"Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells","volume":"5","author":"Samel","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb0865","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biochi.2018.04.017","article-title":"Cellular mechanism of resistance of human colorectal adenocarcinoma cells against apoptosis-induction by Russell's Viper venom l-amino acid oxidase (Rusvinoxidase)","volume":"150","author":"Mukherjee","year":"2018","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb0870","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s10495-015-1157-6","article-title":"Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom l-amino acid oxidase (Rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production","volume":"20","author":"Mukherjee","year":"2015","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0875","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0887-2333(03)00010-9","article-title":"Apoptotic effect in the glioma cells induced by specific protein extracted from Okinawa Habu (Trimeresurus flavoviridis) venom in relation to oxidative stress","volume":"17","author":"Sun","year":"2003","journal-title":"Toxicol. in Vitro"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189479_bb0880","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.lfs.2006.12.024","article-title":"ACTX-8, a cytotoxic l-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells","volume":"80","author":"Zhang","year":"2007","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0885","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1742-7843.2008.00229.x","article-title":"Antitumoural effect of an l-Amino acid oxidase isolated from Bothrops jararaca Snake Venom","volume":"102","author":"De Vieira Santos","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0890","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bcpt.12155","article-title":"Antiproliferative activity of King Cobra (Ophiophagus hannah) Venom l-Amino acid oxidase","volume":"114","author":"Li Lee","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb0895","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/ijms.8096","article-title":"King cobra (Ophiophagus hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model","volume":"11","author":"Lee","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb0900","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jep.2017.11.026","article-title":"Isolation and pharmacological characterization of a new cytotoxic L-amino acid oxidase from Bungarus multicinctus snake venom","volume":"213","author":"Lu","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189479_bb0905","doi-asserted-by":"crossref","first-page":"9539","DOI":"10.1074\/jbc.272.14.9539","article-title":"Apoxin I, a novel apoptosis-inducing factor with <span class=\"small\">L<\/span>-amino acid oxidase activity purified from western diamondback rattlesnake venom *","volume":"272","author":"Torii","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb0910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijbiomac.2017.05.025","article-title":"A new l-amino acid oxidase from Bothrops jararacussu snake venom: isolation, partial characterization, and assessment of pro-apoptotic and antiprotozoal activities","volume":"103","author":"Carone","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0915","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijbiomac.2019.01.059","article-title":"Cytotoxic, genotoxic, and oxidative stress-inducing effect of an l-amino acid oxidase isolated from Bothrops jararacussu venom in a co-culture model of HepG2 and HUVEC cells","volume":"127","author":"Machado","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0920","article-title":"Bothrops moojeni L-amino acid oxidase induces apoptosis and epigenetic modulation on Bcr-Abl(+) cells","volume":"26","author":"Burin","year":"2020","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0925","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbagen.2011.04.003","article-title":"Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from Bothrops leucurus venom","volume":"1810","author":"Naumann","year":"2011","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0930","doi-asserted-by":"crossref","first-page":"42673","DOI":"10.1038\/srep42673","article-title":"CR-LAAO, an L-amino acid oxidase from Calloselasma rhodostoma venom, as a potential tool for developing novel immunotherapeutic strategies against cancer","volume":"7","author":"Costa","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb0935","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cbpa.2008.07.007","article-title":"Evidence of caspase-mediated apoptosis induced by l-amino acid oxidase isolated from Bothrops atrox snake venom","volume":"151","author":"Alves","year":"2008","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"10.1016\/j.bbcan.2025.189479_bb0940","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.toxicon.2018.06.064","article-title":"l-Amino acid oxidase from Cerastes vipera snake venom: isolation, characterization and biological effects on bacteria and tumor cell lines","volume":"150","author":"Salama","year":"2018","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0945","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.procbio.2012.04.020","article-title":"A novel disintegrin protein from Naja naja venom induces cytotoxicity and apoptosis in human cancer cell lines in vitro","volume":"47","author":"Thangam","year":"2012","journal-title":"Process Biochem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0950","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxicon.2011.05.013","article-title":"Leucurogin, a new recombinant disintegrin cloned from Bothrops leucurus (white-tailed-jararaca) with potent activity upon platelet aggregation and tumor growth","volume":"58","author":"Higuchi","year":"2011","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0955","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1009059210733","article-title":"Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis","volume":"3","author":"Zhou","year":"1999","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0960","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.toxicon.2007.07.016","article-title":"Effect of RGD-disintegrins on melanoma cell growth and metastasis: Involvement of the actin cytoskeleton, FAK and c-Fos","volume":"50","author":"Oliva","year":"2007","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0965","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00204-008-0358-y","article-title":"Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion","volume":"83","author":"S\u00e1nchez","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0970","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/toxins8070206","article-title":"Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells","volume":"8","author":"Hammouda","year":"2016","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb0975","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mc.22470","article-title":"Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression","volume":"56","author":"Zakraoui","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb0980","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1349-7006.1992.tb01995.x","article-title":"Triflavin, an arg-gly-asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization","volume":"83","author":"Sheu","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb0985","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.toxicon.2006.12.013","article-title":"Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin","volume":"49","author":"Tian","year":"2007","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb0990","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.matbio.2013.01.001","article-title":"Inhibition of integrins \u03b1v\/\u03b15-dependent functions in melanoma cells by an ECD-disintegrin acurhagin-C","volume":"32","author":"Shih","year":"2013","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb0995","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.matbio.2009.09.009","article-title":"Leberagin-C, A disintegrin-like\/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion","volume":"29","author":"Limam","year":"2010","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb1000","first-page":"2020","article-title":"Obtustatin: a potent selective inhibitor of \u03b11\u03b21 integrin in vitro and angiogenesis in vivo1","volume":"63","author":"Marcinkiewicz","year":"2003","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189479_bb1005","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4161\/cbt.8.15.8999","article-title":"Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis","volume":"8","author":"Staniszewska","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2025.189479_bb1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2022.02.001","article-title":"Alternagin-C, an alpha2beta1 integrin ligand, attenuates collagen-based adhesion, stimulating the metastasis suppressor 1 expression in triple-negative breast tumor cells","volume":"210","author":"Moritz","year":"2022","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.toxicon.2011.12.002","article-title":"Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28","volume":"59","author":"Carey","year":"2012","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.toxicon.2011.02.014","article-title":"Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake","volume":"57","author":"Lucena","year":"2011","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1211\/0022357022160","article-title":"Inhibitory effect of salmosin, a Korean snake venomderived disintegrin, on the integrin \u03b1v-mediated proliferation of SK-Mel-2 human melanoma cells","volume":"55","author":"Chung","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010929","article-title":"Vicrostatin \u2013 an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities","volume":"5","author":"Minea","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb1035","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.biochi.2012.04.020","article-title":"Blocking \u03b1v\u03b23 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells","volume":"94","author":"Montenegro","year":"2012","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2011.10.012","article-title":"BJcuL, a lectin purified from Bothrops jararacussu venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly","volume":"59","author":"Nolte","year":"2012","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1045","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/toxins4100862","article-title":"Vixapatin (VP12), a C-type lectin-protein from vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound","volume":"4","author":"Momic","year":"2012","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb1050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxicon.2016.12.013","article-title":"Daboialectin, a C-type lectin from Russell's viper venom induces cytoskeletal damage and apoptosis in human lung cancer cells in vitro","volume":"127","author":"Pathan","year":"2017","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/labinvest.3700088","article-title":"Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells","volume":"84","author":"Sarray","year":"2004","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbagen.2017.11.019","article-title":"Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin","volume":"1862","author":"Hammouda","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.toxicon.2010.05.016","article-title":"A lethal cardiotoxic\u2013cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom","volume":"56","author":"Debnath","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxicon.2016.08.004","article-title":"NKCT1 (purified Naja kaouthia protein toxin) conjugated gold nanoparticles induced Akt\/mTOR inactivation mediated autophagic and caspase 3 activated apoptotic cell death in leukemic cell","volume":"121","author":"Bhowmik","year":"2016","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxicon.2006.09.009","article-title":"A heat stable protein toxin (drCT-I) from the Indian Viper (Daboia russelli russelli) venom having antiproliferative, cytotoxic and apoptotic activities","volume":"49","author":"Gomes","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxicon.2019.06.220","article-title":"Cytotoxicity of Nubein6.8 peptide isolated from the snake venom of Naja nubiae on melanoma and ovarian carcinoma cell lines","volume":"168","author":"Abdel-Ghani","year":"2019","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20041892","article-title":"Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage","volume":"390","author":"Feofanov","year":"2005","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1090","first-page":"314","article-title":"Anticancer activity of cobra venom polypeptide, cytotoxin-II, against human breast adenocarcinoma cell line (MCF-7) via the induction of apoptosis","volume":"17","author":"Ebrahim","year":"2014","journal-title":"JBC"},{"key":"10.1016\/j.bbcan.2025.189479_bb1095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ijbiomac.2020.06.130","article-title":"Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: a potential treatment for breast cancer","volume":"162","author":"Derakhshani","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1100","first-page":"415","article-title":"Isolation and characterization of a cytotoxin P4 from the venom of Naja nigricollis nigricollis preferentially active on tumor cells","volume":"24","author":"Chaim-Matyas","year":"1991","journal-title":"Biochem. Int."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb1105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.toxicon.2011.04.012","article-title":"Cytotoxic and antioxidant property of a purified fraction (NN-32) of Indian Naja naja venom on Ehrlich ascites carcinoma in BALB\/c mice","volume":"57","author":"Das","year":"2011","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.toxicon.2007.11.024","article-title":"Taiwan cobra cardiotoxins induce apoptotic death of human neuroblastoma SK-N-SH cells mediated by reactive oxygen species generation and mitochondrial depolarization","volume":"51","author":"Chen","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111254","article-title":"Exploring the anticancer potential of Cytotoxin 10 from Naja kaouthia venom: mechanistic insights from breast and lung cancer cell lines","volume":"403","author":"Basumatary","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbcan.2025.189479_bb1120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S1678-91992012000100004","article-title":"Tumor cytotoxicity of leucurolysin-B, a P-III snake venom metalloproteinase from Bothrops leucurus","volume":"18","author":"Gabriel","year":"2012","journal-title":"J. Venom. Anim. Toxins Includ. Tropic. Diseas."},{"key":"10.1016\/j.bbcan.2025.189479_bb1125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.toxicon.2016.08.006","article-title":"Purification of nasulysin-1: a new toxin from Porthidium nasutum snake venom that specifically induces apoptosis in leukemia cell model through caspase-3 and apoptosis-inducing factor activation","volume":"120","author":"Bonilla-Porras","year":"2016","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.toxicon.2011.01.007","article-title":"Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells","volume":"57","author":"Teklemariam","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijbiomac.2017.01.064","article-title":"In vitro antitumor and antiangiogenic effects of Bothropoidin, a metalloproteinase from Bothrops pauloensis snake venom","volume":"97","author":"Guimar\u00e3es","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189479_bb1140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2013.11.009","article-title":"Hemorrhagin VaH4, a covalent heterodimeric P-III metalloproteinase from Vipera ammodytes ammodytes with a potential antitumour activity","volume":"77","author":"Leonardi","year":"2014","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0041-0101(01)00275-6","article-title":"Inhibition of melanoma cells tumorigenicity by the snake venom toxin jararhagin","volume":"40","author":"Corr\u00eaa","year":"2002","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1150","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.toxicon.2012.03.023","article-title":"Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation","volume":"60","author":"Samel","year":"2012","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.toxicon.2009.08.016","article-title":"Expression, purification and characterization of recombinant Jerdonitin, a P-II class snake venom metalloproteinase comprising metalloproteinase and disintegrin domains","volume":"55","author":"Zhu","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.06.020","article-title":"Immunomodulatory actions and epigenetic alterations induced by proteases from Bothrops snake venoms in human immune cells","volume":"61","author":"Menaldo","year":"2019","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bbcan.2025.189479_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107213","article-title":"Biological activities of Vipegrin, an anti-adhesive Kunitz-type serine proteinase inhibitor purified from Russell's viper venom","volume":"232","author":"Bhattacharya","year":"2023","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1170","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1038\/s41598-020-61258-x","article-title":"Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities","volume":"10","author":"Boldrini-Fran\u00e7a","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.matbio.2012.11.015","article-title":"PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells","volume":"32","author":"Morjen","year":"2013","journal-title":"Matrix Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1180","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.toxicon.2011.02.002","article-title":"Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo","volume":"57","author":"Xie","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bbcan.2025.189479_bb1185","series-title":"Antitumor Action of Crotalase, a Defibrinogenating Snake Venom Enzyme, Seminars in thrombosis and hemostasis","first-page":"284","author":"Markland","year":"1986"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2221-1691(13)60042-8","article-title":"Therapeutic potential of snake venom in cancer therapy: current perspectives","volume":"3","author":"Vyas","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/molecules23030692","article-title":"Anticancer activity of toxins from bee and snake venom\u2014an overview on ovarian cancer","volume":"23","author":"Moga","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189479_bb1200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28207165","article-title":"Peptides as therapeutic agents: challenges and opportunities in the green transition era","volume":"28","author":"Rossino","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb1205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1365\/s10337-007-0215-9","article-title":"Chromatographic techniques for the separation of peptides: application to proteomics","volume":"65","author":"Gedela","year":"2007","journal-title":"Chromatographia"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/psc.2836","article-title":"Advances in Fmoc solid-phase peptide synthesis","volume":"22","author":"Behrendt","year":"2016","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3762\/bjoc.10.118","article-title":"Automated solid-phase peptide synthesis to obtain therapeutic peptides","volume":"10","author":"M\u00e4de","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb1220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fbioe.2020.00162","article-title":"Challenges and perspectives in chemical synthesis of highly hydrophobic peptides","volume":"8","author":"Mueller","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1225","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1038\/s41467-023-42434-9","article-title":"Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides","volume":"14","author":"Pandi","year":"2023","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189479_bb1230","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1039\/c3lc50632k","article-title":"An automated Teflon microfluidic peptide synthesizer","volume":"13","author":"Zheng","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.bbcan.2025.189479_bb1235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4684-0997-0_16","article-title":"Use of recombinant DNA technology for the production of polypeptides","volume":"118","author":"Miller","year":"1979","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ddr.21456","article-title":"Harnessing snake venom phospholipases A(2) to novel approaches for overcoming antibiotic resistance","volume":"80","author":"Almeida","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cellbi.2006.11.007","article-title":"Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms","volume":"31","author":"Araya","year":"2007","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cimb44010004","article-title":"Lessons from a single amino acid substitution: anticancer and antibacterial properties of two phospholipase A(2)-derived peptides","volume":"44","author":"Almeida","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189479_bb1255","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1021\/acs.jmedchem.5b01142","article-title":"Structural dissection of crotalicidin, a rattlesnake venom cathelicidin, retrieves a fragment with antimicrobial and antitumor activity","volume":"58","author":"Falcao","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb1260","series-title":"Toxins and Drug Discovery","first-page":"129","article-title":"Antiproliferative effects of snake venom phospholipases A2 and their perspectives for cancer treatment","author":"Osipov","year":"2017"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1265","article-title":"Oxineur, a novel peptide from Caspian cobra Naja naja oxiana against HT-29 colon cancer","volume":"1867","author":"Sadat","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) General Subj."},{"key":"10.1016\/j.bbcan.2025.189479_bb1270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cbi.2016.09.004","article-title":"Mechanism of apoptosis induction in human breast cancer MCF-7 cell by Ruviprase, a small peptide from Daboia russelii russelii venom","volume":"258","author":"Thakur","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1275","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12906-017-2018-3","article-title":"Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines","volume":"17","author":"Attarde","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10989-023-10527-0","article-title":"Anticancer potential and cytotoxic activity of NN-32, a Snake Venom Peptide, against A549, lung cancer cell line","volume":"29","author":"Kurkute","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10989-023-10493-7","article-title":"Batroxin I: a novel bradykinin-potentiating peptide with cytotoxic activity isolated from bothrops atrox snake venom","volume":"29","author":"Cintra","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00726-017-2513-3","article-title":"Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile","volume":"50","author":"Campeiro","year":"2018","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/toxins12020102","article-title":"Isolation of an anti\u2013tumour disintegrin: Dabmaurin\u20131, a Peptide Lebein\u20131\u2013like, from Daboia mauritanica Venom","volume":"12","author":"Chalier","year":"2020","journal-title":"Toxins"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1300","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/toxins16100433","article-title":"Antiproliferative effects of naja anchietae and naja senegalensis venom peptides on glioblastoma cell lines","volume":"16","author":"Boughanmi","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb1305","first-page":"16","article-title":"Peptides with in vitro anti-tumor activity from the venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae)","volume":"5","author":"Conlon","year":"2014","journal-title":"J. Venom Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1310","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/jth.12519","article-title":"Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation","volume":"12","author":"Chang","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb1315","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/molecules29071646","article-title":"3-NAntC: a potent crotoxin B-derived peptide against the triple-negative MDA-MB-231 breast cancer cell line","volume":"29","author":"Bezerra","year":"2024","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.028","article-title":"BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice","volume":"707","author":"Wang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1325","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3892\/or.2013.2693","article-title":"The cathelicidin-BF Lys16 mutant Cbf-K16 selectively inhibits non-small cell lung cancer proliferation in vitro","volume":"30","author":"Tian","year":"2013","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb1330","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/biomedicines10092110","article-title":"Examining topoisomers of a snake-venom-derived peptide for improved antimicrobial and antitumoral properties","volume":"10","author":"Carrera-Aubesart","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb1335","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00530-17","article-title":"Genomewide analysis of the antimicrobial peptides in python bivittatus and characterization of cathelicidins with potent antimicrobial activity and low cytotoxicity","volume":"61","author":"Kim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1340","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/toxins15110622","article-title":"Unveiling the venom composition of the colombian coral snakes micrurus helleri, M. Medemi, and M. Sangilensis","volume":"15","author":"Rodr\u00edguez-Vargas","year":"2023","journal-title":"Toxins"},{"issue":"23","key":"10.1016\/j.bbcan.2025.189479_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1350","article-title":"Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay","volume":"81","author":"Ganot","year":"2013","journal-title":"J. Visualiz. Exp."},{"issue":"59","key":"10.1016\/j.bbcan.2025.189479_bb1355","doi-asserted-by":"crossref","first-page":"100908","DOI":"10.18632\/oncotarget.21740","article-title":"Venom-based peptide therapy: insights into anti-cancer mechanism","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189479_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131990","article-title":"Emerging anticancer potential and mechanisms of snake venom toxins: a review","volume":"269","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189479_bb1365","article-title":"Editorial: therapeutic drug monitoring and clinical toxicology of anti-cancer drugs","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb1370","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cclet.2018.05.027","article-title":"Methods for engineering therapeutic peptides","volume":"29","author":"Li","year":"2018","journal-title":"Chin. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189479_bb1375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168469","article-title":"Effect of L- to D-amino acid substitution on stability and activity of antitumor peptide RDP215 against human melanoma and glioblastoma","volume":"22","author":"Maxian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108103","article-title":"Design, synthesis and activity evaluation of reduction-responsive anticancer peptide temporin-1CEa drug conjugates","volume":"154","author":"Han","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb1385","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170234","article-title":"Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology","volume":"126","author":"Falcao","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.bbcan.2025.189479_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116863","article-title":"Evaluation of crotamine based probes as intracellular targeted contrast agents for magnetic resonance imaging","volume":"69","author":"Joshi","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1395","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb1400","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122686","article-title":"Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy","volume":"14","author":"Tripathi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1405","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (review)","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189479_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116709","article-title":"The role and future prospects of artificial intelligence algorithms in peptide drug development","volume":"175","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10989-024-10602-0","article-title":"Design and characterization of anticancer peptides derived from snake venom metalloproteinase library","volume":"30","author":"Saranya","year":"2024","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bbcan.2025.189479_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.inffus.2023.101945","article-title":"Computational approaches to Explainable Artificial Intelligence: advances in theory, applications and trends","volume":"100","author":"G\u00f3rriz","year":"2023","journal-title":"Inform. Fusion"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1425","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41467-025-60051-6","article-title":"Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence","volume":"16","author":"Guan","year":"2025","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1430","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.fmre.2024.04.021","article-title":"Role of artificial intelligence in revolutionizing drug discovery","volume":"5","author":"Rehman","year":"2024","journal-title":"Fundam. Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb1435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2017.03.038","article-title":"Pharmacological screening technologies for venom peptide discovery","volume":"127","author":"Prashanth","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbcan.2025.189479_bb1440","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1166601","article-title":"Venom biotechnology: casting light on nature\u2019s deadliest weapons using synthetic biology","volume":"11","author":"L\u00fcddecke","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1445","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/biom15040524","article-title":"Molecular modelling in bioactive peptide discovery and characterisation","volume":"15","author":"Agoni","year":"2025","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054328","article-title":"Accelerating the discovery of anticancer peptides through deep forest architecture with deep graphical representation","volume":"24","author":"Yao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1455","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10462-025-11148-3","article-title":"Bridging machine learning and peptide design for cancer treatment: a comprehensive review","volume":"58","author":"Rezaee","year":"2025","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.bbcan.2025.189479_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122586","article-title":"Erythrocyte haemotoxicity profiling of snake venom toxins after nanofractionation","volume":"1176","author":"Xie","year":"2021","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1465","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050997","article-title":"Development of anticancer peptides using artificial intelligence and combinational therapy for cancer therapeutics","volume":"14","author":"Hwang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1470","article-title":"Traditional and computational screening of non-toxic peptides and approaches to improving selectivity","volume":"15","author":"Robles-Loaiza","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1475","doi-asserted-by":"crossref","first-page":"16992","DOI":"10.1038\/s41598-024-67433-8","article-title":"PLMACPred prediction of anticancer peptides based on protein language model and wavelet denoising transformation","volume":"14","author":"Arif","year":"2024","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189479_bb1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40265","article-title":"Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery","volume":"10","author":"Hashemi","year":"2024","journal-title":"Heliyon"},{"issue":"D1","key":"10.1016\/j.bbcan.2025.189479_bb1485","doi-asserted-by":"crossref","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: a database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1490","doi-asserted-by":"crossref","first-page":"21341","DOI":"10.1038\/s41598-022-25530-6","article-title":"ApInAPDB: a database of apoptosis-inducing anticancer peptides","volume":"12","author":"Faraji","year":"2022","journal-title":"Sci. Rep."},{"issue":"Database issue","key":"10.1016\/j.bbcan.2025.189479_bb1495","doi-asserted-by":"crossref","first-page":"D444","DOI":"10.1093\/nar\/gkt1008","article-title":"Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides","volume":"42","author":"Gautam","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb1500","series-title":"Proceedings of the 2018 2nd International Conference on Computational Biology and Bioinformatics","first-page":"32","article-title":"Snake venom database (SVDB): a potential resource for complementary & alternative medicine and drug designing","author":"Hossain","year":"2018"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1505","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae444","article-title":"Reinforcement learning-driven exploration of peptide space: accelerating generation of drug-like peptides","volume":"25","author":"Wang","year":"2024","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100842","article-title":"Machine learning tools for peptide bioactivity evaluation \u2013 implications for cell culture media optimization and the broader cultivated meat industry","volume":"9","author":"Isaac","year":"2024","journal-title":"Curr. Res. Food Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1515","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/srep02984","article-title":"In silico models for designing and discovering novel anticancer peptides","volume":"3","author":"Tyagi","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189479_bb1520","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jtbi.2013.08.037","article-title":"Predicting anticancer peptides with Chou\u2032s pseudo amino acid composition and investigating their mutagenicity via Ames test","volume":"341","author":"Hajisharifi","year":"2014","journal-title":"J. Theor. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10989-014-9435-7","article-title":"ACPP: a web server for prediction and design of anti-cancer peptides","volume":"21","author":"Vijayakumar","year":"2015","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189479_bb1530","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.18632\/oncotarget.7815","article-title":"iACP: a sequence-based tool for identifying anticancer peptides","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1535","doi-asserted-by":"crossref","first-page":"33910","DOI":"10.1038\/srep33910","article-title":"Identifying anticancer peptides by using improved hybrid compositions","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"44","key":"10.1016\/j.bbcan.2025.189479_bb1540","doi-asserted-by":"crossref","first-page":"77121","DOI":"10.18632\/oncotarget.20365","article-title":"MLACP: machine-learning-based prediction of anticancer peptides","volume":"8","author":"Manavalan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189479_bb1545","series-title":"Proceedings of the 2017 4th International Conference on Biomedical and Bioinformatics Engineering","first-page":"91","article-title":"Identification of anticancer peptides using optimal feature space of Chou's split amino acid composition and support vector machine","author":"Khan","year":"2017"},{"key":"10.1016\/j.bbcan.2025.189479_bb1550","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.artmed.2017.06.008","article-title":"iACP-GAEnsC: evolutionary genetic algorithm based ensemble classification of anticancer peptides by utilizing hybrid feature space","volume":"79","author":"Akbar","year":"2017","journal-title":"Artif. Intell. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189479_bb1555","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1093\/bioinformatics\/bty451","article-title":"ACPred-FL: a sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides","volume":"34","author":"Wei","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1560","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/genes9030158","article-title":"A novel hybrid sequence-based model for identifying anticancer peptides","volume":"9","author":"Xu","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.bbcan.2025.189479_bb1565","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chemolab.2018.09.007","article-title":"Intelligent computational method for discrimination of anticancer peptides by incorporating sequential and evolutionary profiles information","volume":"182","author":"Kabir","year":"2018","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.bbcan.2025.189479_bb1570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","article-title":"ACP-DL: a deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation","volume":"17","author":"Yi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1575","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/molecules24101973","article-title":"ACPred: a computational tool for the prediction and analysis of anticancer peptides","volume":"24","author":"Schaduangrat","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb1580","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/ijms20081964","article-title":"mACPpred: a support vector machine-based meta-predictor for identification of anticancer peptides","volume":"20","author":"Boopathi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb1585","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12859-019-2766-9","article-title":"An advanced approach to identify antimicrobial peptides and their function types for penaeus through machine learning strategies","volume":"20","author":"Lin","year":"2019","journal-title":"BMC Bioinform."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1590","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa153","article-title":"AntiCP 2.0: an updated model for predicting anticancer peptides","volume":"22","author":"Agrawal","year":"2020","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1595","doi-asserted-by":"crossref","first-page":"131939","DOI":"10.1109\/ACCESS.2020.3009125","article-title":"cACP-2LFS: classification of anticancer peptides using sequential discriminative model of KSAAP and two-level feature selection approach","volume":"8","author":"Akbar","year":"2020","journal-title":"IEEE Access"},{"key":"10.1016\/j.bbcan.2025.189479_bb1600","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00760","article-title":"EnACP: an ensemble learning model for identification of anticancer peptides","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2025.189479_bb1605","doi-asserted-by":"crossref","first-page":"176005","DOI":"10.1109\/ACCESS.2020.3023800","article-title":"ACP-GCN: the identification of anticancer peptides based on graph convolution networks","volume":"8","author":"Rao","year":"2020","journal-title":"IEEE Access"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1610","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bib\/bbz088","article-title":"ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides","volume":"21","author":"Rao","year":"2019","journal-title":"Brief. Bioinform."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1615","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/pharmaceutics12111045","article-title":"CancerGram: an effective classifier for differentiating anticancer from antimicrobial peptides","volume":"12","author":"Burdukiewicz","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189479_bb1620","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.omtn.2020.10.005","article-title":"DeepACP: a novel computational approach for accurate identification of anticancer peptides by deep learning algorithm","volume":"22","author":"Yu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbcan.2025.189479_bb1625","series-title":"2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","first-page":"2585","article-title":"Prediction of anticancer peptides with dictionary learning method","author":"Ge","year":"2020"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189479_bb1630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12859-020-03812-y","article-title":"DRACP: a novel method for identification of anticancer peptides","volume":"21","author":"Zhao","year":"2020","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1635","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00892","article-title":"Prediction of anticancer peptides using a low-dimensional feature model","volume":"8","author":"Li","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1640","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s10989-021-10222-y","article-title":"ACHP: a web server for predicting anti-cancer peptide and anti-hypertensive peptide","volume":"27","author":"Xu","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bbcan.2025.189479_bb1645","article-title":"ACP-DA: improving the prediction of anticancer peptides using data augmentation","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1650","doi-asserted-by":"crossref","first-page":"23676","DOI":"10.1038\/s41598-021-02703-3","article-title":"ACP-MHCNN: an accurate multi-headed deep-convolutional neural network to predict anticancer peptides","volume":"11","author":"Ahmed","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189479_bb1655","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11906","article-title":"DLFF-ACP: prediction of ACPs based on deep learning and multi-view features fusion","volume":"9","author":"Cao","year":"2021","journal-title":"PeerJ"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1660","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab008","article-title":"Anticancer peptides prediction with deep representation learning features","volume":"22","author":"Lv","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1665","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/s41598-021-82513-9","article-title":"Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method","volume":"11","author":"Charoenkwan","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1670","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab209","article-title":"iAMP-CA2L: a new CNN-BiLSTM-SVM classifier based on cellular automata image for identifying antimicrobial peptides and their functional types","volume":"22","author":"Xiao","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1675","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab414","article-title":"Identifying multi-functional bioactive peptide functions using multi-label deep learning","volume":"23","author":"Tang","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1680","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab358","article-title":"PreTP-EL: prediction of therapeutic peptides based on ensemble learning","volume":"22","author":"Guo","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb1685","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/acs.jcim.1c00181","article-title":"xDeep-AcPEP: deep learning method for anticancer peptide activity prediction based on convolutional neural network and multitask learning","volume":"61","author":"Chen","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1690","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12859-021-04433-9","article-title":"CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1695","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2022.104589","article-title":"ACP-2DCNN: deep learning-based model for improving prediction of anticancer peptides using two-dimensional convolutional neural network","volume":"226","author":"Ghulam","year":"2022","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.bbcan.2025.189479_bb1700","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105868","article-title":"ACP-check: an anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy","volume":"148","author":"Zhu","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189479_bb1705","article-title":"Anticancer peptide prediction via multi-Kernel CNN and attention model","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1710","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/molecules27051544","article-title":"ACPNet: a deep learning network to identify anticancer peptides by hybrid sequence information","volume":"27","author":"Sun","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bbcan.2025.189479_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105459","article-title":"ME-ACP: multi-view neural networks with ensemble model for identification of anticancer peptides","volume":"145","author":"Feng","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1720","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/ph15060707","article-title":"MPMABP: a CNN and Bi-LSTM-based method for predicting multi-activities of bioactive peptides","volume":"15","author":"Li","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbcan.2025.189479_bb1725","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2022.104490","article-title":"Pep-CNN: an improved convolutional neural network for predicting therapeutic peptides","volume":"221","author":"Zhang","year":"2022","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.bbcan.2025.189479_bb1730","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1016\/j.csbj.2022.07.043","article-title":"MLACP 2.0: An updated machine learning tool for anticancer peptide prediction","volume":"20","author":"Thi Phan","year":"2022","journal-title":"Comp. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1735","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1109\/TCBB.2022.3183018","article-title":"PreTP-stack: prediction of therapeutic peptide based on the stacked ensemble learning","volume":"20","author":"Yan","year":"2023","journal-title":"IEEE\/ACM Trans. Comp. Biol. Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1740","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2021.104458","article-title":"StackACPred: prediction of anticancer peptides by integrating optimized multiple feature descriptors with stacked ensemble approach","volume":"220","author":"Arif","year":"2022","journal-title":"Chemom. Intell. Lab. Syst."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1745","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/bioinformatics\/btac200","article-title":"TPpred-ATMV: therapeutic peptide prediction by adaptive multi-view tensor learning model","volume":"38","author":"Yan","year":"2022","journal-title":"Bioinformatics"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189479_bb1750","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.3390\/ijms242015447","article-title":"ACP-BC: a model for accurate identification of anticancer peptides based on fusion features of bidirectional long short-term memory and chemically derived information","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1755","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106844","article-title":"ACP-MLC: a two-level prediction engine for identification of anticancer peptides and multi-label classification of their functional types","volume":"158","author":"Deng","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189479_bb1760","article-title":"ACP-GBDT: An improved anticancer peptide identification method with gradient boosting decision tree","volume":"14","author":"Li","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1062936X.2022.2160011","article-title":"iACP-GE: accurate identification of anticancer peptides by using gradient boosting decision tree and extra tree","volume":"34","author":"Liang","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb1770","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107915","article-title":"ANNprob-ACPs: a novel anticancer peptide identifier based on probabilistic feature fusion approach","volume":"169","author":"Karim","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1775","doi-asserted-by":"crossref","first-page":"22843","DOI":"10.1038\/srep22843","article-title":"A web server and mobile app for computing hemolytic potency of peptides","volume":"6","author":"Chaudhary","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb1780","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4155\/fmc-2016-0188","article-title":"Hemopred: a web server for predicting the hemolytic activity of peptides","volume":"9","author":"Win","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb1785","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00054","article-title":"A method for predicting hemolytic potency of chemically modified peptides from its structure","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1790","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1038\/s41598-020-67701-3","article-title":"HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks","volume":"10","author":"Timmons","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1795","doi-asserted-by":"crossref","first-page":"16581","DOI":"10.1038\/s41598-020-73644-6","article-title":"Machine learning-guided discovery and design of non-hemolytic peptides","volume":"10","author":"Plisson","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1800","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/bioinformatics\/btaa160","article-title":"HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation","volume":"36","author":"Hasan","year":"2020","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1805","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12859-022-04952-z","article-title":"AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning","volume":"23","author":"Salem","year":"2022","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1810","article-title":"Hemolytic-Pred: a machine learning-based predictor for hemolytic proteins using position and composition-based features","volume":"9","author":"Perveen","year":"2023","journal-title":"Digit. Health"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1815","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1109\/JBHI.2023.3264941","article-title":"EnDL-HemoLyt: ensemble deep learning-based tool for identifying therapeutic peptides with low hemolytic activity","volume":"28","author":"Sharma","year":"2024","journal-title":"IEEE J. Biomed. Health Inform."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb1820","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1021\/acs.jcim.2c01317","article-title":"Serverless prediction of peptide properties with recurrent neural networks","volume":"63","author":"Ansari","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"46","key":"10.1016\/j.bbcan.2025.189479_bb1825","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1021\/acs.jpclett.3c02398","article-title":"PeptideBERT: a language model based on transformers for peptide property prediction","volume":"14","author":"Guntuboina","year":"2023","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.bbcan.2025.189479_bb1830","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2024.115523","article-title":"HemoDL: Hemolytic peptides prediction by double ensemble engines from Rich sequence-derived and transformer-enhanced information","volume":"690","author":"Yang","year":"2024","journal-title":"Anal. Biochem."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1835","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11128-024-04540-5","article-title":"Non-hemolytic peptide classification using a quantum support vector machine","volume":"23","author":"Zhuang","year":"2024","journal-title":"Quantum Inf. Process"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1840","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/acs.jcim.4c01443","article-title":"Multi-peptide: multimodality leveraged language-graph learning of peptide properties","volume":"65","author":"Badrinarayanan","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1845","article-title":"HemoFuse: multi-feature fusion based on multi-head cross-attention for identification of hemolytic peptides","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1850","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s42003-025-07615-w","article-title":"Prediction of hemolytic peptides and their hemolytic concentration","volume":"8","author":"Rathore","year":"2025","journal-title":"Commun. Biol."},{"issue":"suppl_2","key":"10.1016\/j.bbcan.2025.189479_bb1855","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gkp299","article-title":"ClanTox: a classifier of short animal toxins","volume":"37","author":"Naamati","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb1860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189479_bb1865","article-title":"Machine learning can differentiate venom toxins from other proteins having non-toxic physiological functions","volume":"2","author":"Gacesa","year":"2016","journal-title":"PeerJ Comp. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1870","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7200","article-title":"TOXIFY: a deep learning approach to classify animal venom proteins","volume":"7","author":"Cole","year":"2019","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1875","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1038\/s41598-019-54405-6","article-title":"NNTox: gene ontology-based protein toxicity prediction using neural network","volume":"9","author":"Jain","year":"2019","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189479_bb1880","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1093\/bioinformatics\/btaa656","article-title":"ToxDL: deep learning using primary structure and domain embeddings for assessing protein toxicity","volume":"36","author":"Pan","year":"2020","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1885","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab041","article-title":"ATSE: a peptide toxicity predictor by exploiting structural and evolutionary information based on graph neural network and attention mechanism","volume":"22","author":"Wei","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1890","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/bioinformatics\/btac006","article-title":"ToxIBTL: prediction of peptide toxicity based on information bottleneck and transfer learning","volume":"38","author":"Wei","year":"2022","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb1895","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac174","article-title":"ToxinPred2: an improved method for predicting toxicity of proteins","volume":"23","author":"Sharma","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"44","key":"10.1016\/j.bbcan.2025.189479_bb1900","doi-asserted-by":"crossref","first-page":"40569","DOI":"10.1021\/acsomega.2c05881","article-title":"Improved prediction model of protein and peptide toxicity by integrating channel attention into a convolutional neural network and gated recurrent units","volume":"7","author":"Zhao","year":"2022","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1905","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020431","article-title":"CSM-toxin: a web-server for predicting protein toxicity","volume":"15","author":"Morozov","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb1910","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae270","article-title":"VISH-Pred: an ensemble of fine-tuned ESM models for protein toxicity prediction","volume":"25","author":"Mall","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb1915","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5076","article-title":"Structure-aware deep learning model for peptide toxicity prediction","volume":"33","author":"Ebrahimikondori","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb1920","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108926","article-title":"ToxinPred 3.0: an improved method for predicting the toxicity of peptides","volume":"179","author":"Rathore","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"29","key":"10.1016\/j.bbcan.2025.189479_bb1925","doi-asserted-by":"crossref","first-page":"32116","DOI":"10.1021\/acsomega.4c04246","article-title":"ToxTeller: predicting peptide toxicity using four different machine learning approaches","volume":"9","author":"Wang","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1930","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12859-024-05748-z","article-title":"MultiToxPred 1.0: a novel comprehensive tool for predicting 27 classes of protein toxins using an ensemble machine learning approach","volume":"25","author":"Beltr\u00e1n","year":"2024","journal-title":"BMC Bioinform."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1935","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae583","article-title":"ToxGIN: an In silico prediction model for peptide toxicity via graph isomorphism networks integrating peptide sequence and structure information","volume":"25","author":"Yu","year":"2024","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bbcan.2025.189479_bb1940","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.csbj.2025.04.002","article-title":"ToxDL 2.0: protein toxicity prediction using a pretrained language model and graph neural networks","volume":"27","author":"Zhu","year":"2025","journal-title":"Comp. Struct. Biotechnol. J."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189479_bb1945","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169115","article-title":"PLPTP: a motif-based interpretable deep learning framework based on protein language models for peptide toxicity prediction","volume":"437","author":"Gao","year":"2025","journal-title":"J. Mol. Biol."},{"issue":"suppl_2","key":"10.1016\/j.bbcan.2025.189479_bb1950","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gkp323","article-title":"PEP-FOLD: an online resource for de novo peptide structure prediction","volume":"37","author":"Maupetit","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1955","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Shen","year":"2014","journal-title":"J. Chem. Theory Comput."},{"issue":"W1","key":"10.1016\/j.bbcan.2025.189479_bb1960","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb1965","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"issue":"W1","key":"10.1016\/j.bbcan.2025.189479_bb1970","doi-asserted-by":"crossref","first-page":"W432","DOI":"10.1093\/nar\/gkad376","article-title":"PEP-FOLD4: a pH-dependent force field for peptide structure prediction in aqueous solution","volume":"51","author":"Rey","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb1975","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/prot.26384","article-title":"Pep\u2013Whisperer: Inhibitory peptide design","volume":"90","author":"Hurwitz","year":"2022","journal-title":"Prot. Struct. Funct. Bioinform."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb1980","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104300","article-title":"Artificial intelligence in peptide-based drug design","volume":"30","author":"Zhai","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb1985","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1021\/acs.jcim.1c01114","article-title":"AlphaFold 2: Why it works and its implications for understanding the relationships of protein sequence, structure, and function","volume":"61","author":"Skolnick","year":"2021","journal-title":"J. Chem. Inform. Model."},{"key":"10.1016\/j.bbcan.2025.189479_bb1990","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.plrev.2022.09.003","article-title":"The distinguishing electrical properties of cancer cells","volume":"43","author":"Di Gregorio","year":"2022","journal-title":"Phys Life Rev"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb1995","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Sign. Transd. Target. Therapy"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2000","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","article-title":"Strategic approaches to improvise peptide drugs as next generation therapeutics","volume":"29","author":"Barman","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bbcan.2025.189479_bb2005","article-title":"Renovation as innovation: repurposing human antibacterial peptide LL-37 for cancer therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189479_bb2010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1463088","article-title":"From defense to offense: antimicrobial peptides as promising therapeutics for cancer","volume":"14","author":"Zare-Zardini","year":"2024","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb2015","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa053","article-title":"Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents","volume":"78","author":"Mendes","year":"2020","journal-title":"Pathogens Disease"},{"key":"10.1016\/j.bbcan.2025.189479_bb2020","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2017.00005","article-title":"Peptides with dual antimicrobial and anticancer activities","volume":"5","author":"Fel\u00edcio","year":"2017","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12934-022-01848-8","article-title":"The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures","volume":"21","author":"Parchebafi","year":"2022","journal-title":"Microb. Cell Factories"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043110","article-title":"Bacterial infections and cancer: exploring this association and its implications for cancer patients","volume":"24","author":"Yusuf","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb2035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fchem.2015.00069","article-title":"Recent advances toward the discovery of drug-like peptides De novo","volume":"3","author":"Goldflam","year":"2015","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ddtec.2004.11.005","article-title":"Drug-like properties: guiding principles for design \u2013 or chemical prejudice?","volume":"1","author":"Leeson","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bbcan.2025.189479_bb2045","series-title":"ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: In silico study, Issue: 4","author":"Khaldun","year":"2022"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb2050","first-page":"165","article-title":"The role of pharmacokinetics and pharmacodynamics in early drug development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine","volume":"11","author":"Hassan","year":"2011","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.bbcan.2025.189479_bb2055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-0716-3441-7_17","article-title":"Artificial intelligence in ADME property prediction","volume":"2714","author":"Siramshetty","year":"2024","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"issue":"W1","key":"10.1016\/j.bbcan.2025.189479_bb2060","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189479_bb2065","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1021\/acs.jcim.4c00295","article-title":"Advancing peptide-based cancer therapy with AI: in-depth analysis of state-of-the-art AI models","volume":"64","author":"Bhattarai","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbcan.2025.189479_bb2070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymeth.2022.07.017","article-title":"AntiMF: a deep learning framework for predicting anticancer peptides based on multi-view feature extraction","volume":"207","author":"Liu","year":"2022","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2075","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac630","article-title":"Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding","volume":"24","author":"Yuan","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2080","article-title":"Peptide-based drug predictions for cancer therapy using deep learning","volume":"15","author":"Sun","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.bbcan.2025.189479_bb2085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117003","article-title":"Effects of data quality and quantity on deep learning for protein-ligand binding affinity prediction","volume":"72","author":"Fan","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189479_bb2090","article-title":"Efficient prediction of anticancer peptides through deep learning","volume":"10","author":"Salam","year":"2024","journal-title":"PeerJ Comp. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ymben.2011.09.002","article-title":"Cell-free synthetic biology: thinking outside the cell","volume":"14","author":"Hodgman","year":"2012","journal-title":"Metab. Eng."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40259-020-00417-y","article-title":"Cell-free protein synthesis: a promising option for future drug development","volume":"34","author":"Dondapati","year":"2020","journal-title":"BioDrugs: Clin. Immunotherap. Biopharm. Gene Therapy"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2105","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040315","article-title":"Cell-free protein synthesis: chassis toward the minimal cell","volume":"8","author":"Yue","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb2110","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1039\/D4CS01198H","article-title":"Cell-free synthetic biology for natural product biosynthesis and discovery","volume":"54","author":"Rice","year":"2025","journal-title":"Chem. Soc. Rev."},{"issue":"69","key":"10.1016\/j.bbcan.2025.189479_bb2115","doi-asserted-by":"crossref","first-page":"17487","DOI":"10.1002\/chem.202103161","article-title":"Easy production of \u201cdifficult peptides\u201d using cell-free protein synthesis and a new methionine analogue as a latent peptide cleavage site","volume":"27","author":"Fankhauser","year":"2021","journal-title":"Chem. Eur. J."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb2120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/biot.201500237","article-title":"Cell-free protein synthesis of a cytotoxic cancer therapeutic: onconase production and a just-add-water cell-free system","volume":"11","author":"Salehi","year":"2016","journal-title":"Biotechnol. J."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00418-008-0469-9","article-title":"MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology","volume":"130","author":"Walch","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189479_bb2130","article-title":"Advances in MALDI mass spectrometry imaging single cell and tissues","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Chem."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189479_bb2135","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.jprot.2012.04.012","article-title":"Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences","volume":"75","author":"Goodwin","year":"2012","journal-title":"J. Proteome"},{"issue":"Spec Issue","key":"10.1016\/j.bbcan.2025.189479_bb2140","article-title":"Effective sample preparations in imaging mass spectrometry","volume":"3","author":"Shimma","year":"2014","journal-title":"Mass Spectrometry (Tokyo, Japan)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb2145","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/jasms.3c00079","article-title":"A MALDI mass spectrometry imaging sample preparation method for venous thrombosis with initial lipid characterization of lab-made and murine clots","volume":"34","author":"McDonald","year":"2023","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189479_bb2150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061384","article-title":"Deciphering tumour heterogeneity: from tissue to liquid biopsy","volume":"14","author":"Gilson","year":"2022","journal-title":"Cancers"},{"issue":"12-13","key":"10.1016\/j.bbcan.2025.189479_bb2155","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202300001","article-title":"Advancing rare cancer research by MALDI mass spectrometry imaging: applications, challenges, and future perspectives in sarcoma","volume":"24","author":"Stillger","year":"2024","journal-title":"Proteomics"},{"key":"10.1016\/j.bbcan.2025.189479_bb2160","series-title":"Advances in Cancer Research","first-page":"133","article-title":"Chapter six - mass spectrometry imaging in oncology drug discovery","author":"Goodwin","year":"2017"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb2165","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10020054","article-title":"Implementation of MALDI mass spectrometry imaging in cancer proteomics research: applications and challenges","volume":"10","author":"Berghmans","year":"2020","journal-title":"J. Personaliz. Med."},{"key":"10.1016\/j.bbcan.2025.189479_bb2170","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116183","article-title":"MALDI-MSI analysis of cancer drugs: Significance, advances, and applications","volume":"136","author":"He","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb2175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40364-024-00643-4","article-title":"Single-cell sequencing to multi-omics: technologies and applications","volume":"12","author":"Wu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2025.189479_bb2185","article-title":"Advancements and applications of single-cell multi-omics techniques in cancer research: unveiling heterogeneity and paving the way for precision therapeutics","volume":"37","author":"Liang","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189479_bb2190","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1021\/acs.analchem.2c00413","article-title":"Single-cell chemical proteomics (SCCP) interrogates the timing and heterogeneity of cancer cell commitment to death","volume":"94","author":"V\u00e9gv\u00e1ri","year":"2022","journal-title":"Anal. Chem."},{"issue":"16_suppl","key":"10.1016\/j.bbcan.2025.189479_bb2195","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.e20540","article-title":"Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors","volume":"40","author":"Sinha","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2200","doi-asserted-by":"crossref","first-page":"12819","DOI":"10.1038\/s41598-025-96465-x","article-title":"A novel peptide RR-171 derived from human umbilical cord serum induces apoptosis and pyroptosis in pancreatic cancer cells","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb2205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.slasd.2023.08.009","article-title":"Evolution and impact of high content imaging","volume":"28","author":"Way","year":"2023","journal-title":"SLAS Discov."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189479_bb2210","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/1087057114528537","article-title":"Increasing the content of high-content screening: an overview","volume":"19","author":"Singh","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbcan.2025.189479_bb2215","series-title":"High Content Imaging in Drug Discovery, Royal Society of Chemistry","author":"Pilling","year":"2025"},{"key":"10.1016\/j.bbcan.2025.189479_bb2220","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102842","article-title":"Artificial intelligence for high content imaging in drug discovery","volume":"87","author":"Carreras-Puigvert","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb2225","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1535-7163.MCT-17-0841","article-title":"A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy","volume":"17","author":"Sidarovich","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189479_bb2230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2017.02.024","article-title":"High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1)","volume":"119","author":"Peterson","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb2235","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.drudis.2015.04.004","article-title":"Pathophysiologically relevant in vitro tumor models for drug screening","volume":"20","author":"Das","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189479_bb2240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071161","article-title":"Mimicking the complexity of solid tumors: how spheroids could advance cancer preclinical transformative approaches","volume":"17","author":"Mangani","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2245","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb2250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1175503","article-title":"3D cancer models: one step closer to in vitro human studies","volume":"14","author":"Manduca","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13578-022-00887-3","article-title":"Three-dimensional in vitro culture models in oncology research","volume":"12","author":"Jubelin","year":"2022","journal-title":"Cell Biosci."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb2260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111863","article-title":"Development of breast cancer spheroids to evaluate cytotoxic response to an anticancer peptide","volume":"13","author":"Cavaco","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189479_bb2265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183264","article-title":"Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies","volume":"1862","author":"Grissenberger","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb2270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/futurepharmacol2020009","article-title":"Snake venom and 3D microenvironment cell culture: from production to drug development","volume":"2","author":"Kato","year":"2022","journal-title":"Future Pharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189479_bb2275","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/biom12020258","article-title":"A new approach to inhibiting triple-negative breast cancer: in vitro, ex vivo and in vivo antiangiogenic effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu venom","volume":"12","author":"de Vasconcelos Azevedo","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189479_bb2280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/toxins13110830","article-title":"Crotoxin modulates events involved in epithelial\u2013mesenchymal transition in 3D spheroid model","volume":"13","author":"Kato","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.bbcan.2025.189479_bb2285","article-title":"PI metalloproteinases and L-amino acid oxidases from Bothrops species inhibit angiogenesis","volume":"27","author":"Bhat","year":"2021","journal-title":"J. Venom. Anim. Toxins Includ. Tropic. Diseas."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2290","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/molecules23040968","article-title":"Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells","volume":"23","author":"Mambelli-Lisboa","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2295","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040968","article-title":"Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells","volume":"23","author":"Mambelli-Lisboa","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2300","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17030136","article-title":"Innovations in snake venom-derived therapeutics: a systematic review of global patents and their pharmacological applications","volume":"17","author":"Zona Rubio","year":"2025","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2305","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1038\/s41598-024-53366-9","article-title":"Differential effects of the venoms of Russell's viper and Indian cobra on human myoblasts","volume":"14","author":"Bin Haidar","year":"2024","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb2310","first-page":"1494","article-title":"Past, present and future of drug conjugates for cancer therapy","volume":"6","author":"Cazzamalli","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2025.189479_bb2315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189479_bb2320","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189479_bb2325","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1021\/acs.chemrev.4c00989","article-title":"Advances in peptidomimetics for next-generation therapeutics: strategies, modifications, and applications","volume":"125","author":"Lombardi","year":"2025","journal-title":"Chem. Rev."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189479_bb2330","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144428","article-title":"Cyclic peptides for the treatment of cancers: a review","volume":"27","author":"Ramadhani","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189479_bb2335","first-page":"337","article-title":"PEGylation in anti-cancer therapy: an overview","volume":"11","author":"Mishra","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bbcan.2025.189479_bb2340","doi-asserted-by":"crossref","first-page":"e70018","DOI":"10.1002\/prca.70018","article-title":"Artificial intelligence and the evolving landscape of immunopeptidomics","volume":"31","author":"Vo","year":"2025","journal-title":"PROTEOMICS Clin. Appl."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2345","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41541-021-00417-1","article-title":"Protein engineering strategies for rational immunogen design","volume":"6","author":"Caradonna","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2025.189479_bb2350","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101727","article-title":"The impact of immunopeptidomics: from basic research to clinical implementation","volume":"66","author":"Shapiro","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189479_bb2355","article-title":"State-of-the-art review on liposomes as versatile cancer vaccine delivery systems","volume":"109","author":"Vatankhah","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbcan.2025.189479_bb2360","doi-asserted-by":"crossref","DOI":"10.2174\/0115748863392869250827042742","article-title":"Global analysis of regulatory frameworks and drug safety standards in the drug approval process","author":"Gomase","year":"2025","journal-title":"Curr. Drug Saf."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189479_bb2365","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/toxins11090488","article-title":"Phylogeny-guided selection of priority groups for venom bioprospecting: harvesting toxin sequences in tarantulas as a case study","volume":"11","author":"L\u00fcddecke","year":"2019","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189479_bb2370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189479_bb2375","first-page":"1033","article-title":"Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer","volume":"8","author":"Cura","year":"2002","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:22:12Z","timestamp":1781065332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25002215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":475,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0304419X25002215"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189479","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189479"}}